NinePoint Medical
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
$33.0m | Series A | ||
$34.0m | Series B | ||
$15.0m | Debt | ||
N/A | $30.7m | Series C | |
N/A | $17.4m | Grant | |
$850k | Grant | ||
Total Funding | AUD179m |
Recent News about NinePoint Medical
EditNinePoint Medical is a medical technology company specializing in advanced imaging systems designed to assist gastroenterologists in detecting abnormalities in the esophagus and bile duct. Operating in the healthcare market, NinePoint Medical's core product, the NvisionVLE Imaging System, offers a high-resolution, volumetric view of both the tissue surface and subsurface, enabling more accurate diagnoses compared to standard white light endoscopy and random biopsy methods. The company primarily serves healthcare providers, particularly those specializing in gastroenterology, by providing them with cutting-edge tools to improve patient care. NinePoint Medical generates revenue through the sale of its imaging systems and associated services, including training and support for medical professionals. The business model focuses on innovation in medical imaging technology to enhance diagnostic capabilities and patient outcomes.
Keywords: medical technology, imaging systems, gastroenterology, esophagus, bile duct, high-resolution, volumetric imaging, healthcare providers, diagnostic tools, patient care.